2022
DOI: 10.1016/j.genrep.2022.101641
|View full text |Cite
|
Sign up to set email alerts
|

miRNA expression in COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 89 publications
2
7
0
Order By: Relevance
“…We used Calu-3, a common, sensitive and effective preclinical model for studying human respiratory processes and lung-injury-related diseases [ 52 ]. Calu-3 is a well-established in vitro model of respiratory virus infection, an alternative approach that mimics the characteristics of bronchial epithelial cells very well [ 53 , 54 ]. However, Calu-3 is a lineage derived from lung adenocarcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…We used Calu-3, a common, sensitive and effective preclinical model for studying human respiratory processes and lung-injury-related diseases [ 52 ]. Calu-3 is a well-established in vitro model of respiratory virus infection, an alternative approach that mimics the characteristics of bronchial epithelial cells very well [ 53 , 54 ]. However, Calu-3 is a lineage derived from lung adenocarcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…Teo et al, in their study with rs8679, found that the total ΔΔG value for miRNA binding was lower in the variant allele versus the wild type ( Teo et al, 2012 ). Many miRNA dysregulations have been demonstrated in patients with COVID-19 ( Paul et al, 2022 ; Roustai Geraylow et al, 2022 ). Demiray et al found that miR-223 decreased in COVID-19 patients compared to healthy controls ( Demiray et al, 2021 ).…”
Section: Discussionmentioning
confidence: 99%
“…45 Since the start of COVID-19, several studies have investigated the possible dysregulation of human miRNAs after SARS-CoV-2 infection in vivo, in vitro, and in silico [46][47][48] Initially, human miRNAs were predicted using computer-assisted techniques that were further validated through in vivo or in vitro studies. [48][49][50] In terms of miRNAs related to SARS-CoV-2/COVID-19, within a short span of only ~2 years, already hundreds of studies have been published. In this systematic review, we not only summarise the currently available data, but also analyse the available data from patients to examine the performance of currently enumerated miRNAs as biomarkers across the globe.…”
Section: Mirnas In Sars-cov-2mentioning
confidence: 99%
“…Moreover, viruses also transcribe miRNAs that may interfere with the host‐cellular defence system 45 . Since the start of COVID‐19, several studies have investigated the possible dysregulation of human miRNAs after SARS‐CoV‐2 infection in vivo, in vitro, and in silico 46–48 Initially, human miRNAs were predicted using computer‐assisted techniques that were further validated through in vivo or in vitro studies 48–50 . In terms of miRNAs related to SARS‐CoV‐2/COVID‐19, within a short span of only ∼2 years, already hundreds of studies have been published.…”
Section: Introductionmentioning
confidence: 99%